chlorisondamine and Disease Models, Animal

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Chlorisondamine; Desoxycorticosterone Acetate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension; Male; Mice, Inbred C57BL; Sodium Chloride, Dietary; Sympathetic Nervous System; Sympatholytics; Vasomotor System

Topics: Animals; Chlorisondamine; Disease Models, Animal; Drug Evaluation, Preclinical; Fatty Acid-Binding Proteins; Hemodynamics; Interleukin-1beta; Intestinal Mucosa; Intestines; Intra-Abdominal Hypertension; Male; Myosin Light Chains; Peptides; Peptides, Cyclic; Random Allocation; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 4; rho-Associated Kinases; Superoxide Dismutase; Tumor Necrosis Factor-alpha

Topics: Animals; Benzodiazepinones; Chlorisondamine; Devazepide; Disease Models, Animal; Endotoxemia; Enteral Nutrition; Inflammation; Lipids; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Phenylurea Compounds; Receptors, Cholecystokinin; Sepsis; Tumor Necrosis Factor-alpha

Topics: Animals; Antihypertensive Agents; Benzopyrans; Chlorisondamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Drug Interactions; Ganglia, Spinal; Hexamethonium; Ligation; Male; Mononeuropathies; Nicotinic Antagonists; Pain; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; Time Factors

Topics: Acetylcholine; Analgesia; Animals; Azetidines; Chlorisondamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mecamylamine; Naloxone; Nicotinic Agonists; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Vincristine

Topics: Anabasine; Animals; Blotting, Western; Chlorisondamine; Cholinergic Agonists; Colitis; Disease Models, Animal; Inflammation; Male; Mice; NF-kappa B; Nicotinic Antagonists; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Chlorisondamine; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Hydralazine; Hypertension; Pentanoic Acids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Thiazolidines; Vasodilator Agents

Topics: Analgesics; Animals; Azetidines; Behavior, Animal; Brain; Chlorisondamine; Cyclophosphamide; Cystitis; Disease Models, Animal; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain; Pyridines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Viscera

Topics: Animals; Antihypertensive Agents; Blood Pressure; Chlorisondamine; Disease Models, Animal; Hypotension, Orthostatic; Macaca fascicularis; Male; Minoxidil; Phentolamine; Prazosin; Propranolol; Sympathetic Nervous System

Topics: Adrenergic alpha-Agonists; Animals; Chlorisondamine; Disease Models, Animal; Eyelids; Follow-Up Studies; Hyperthyroidism; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Oculomotor Muscles; Phenylephrine; Rats; Rats, Sprague-Dawley; Triiodothyronine

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorisondamine; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Subcutaneous; Male; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra

Topics: Administration, Intranasal; Airway Resistance; Animals; Antigens; Ascaris; Asthma; Atropine; Chlorisondamine; Disease Models, Animal; Dogs; Histamine; Lung Compliance; Male; Parasympathomimetics; Physostigmine

Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Catecholamines; Chloralose; Chlorisondamine; Coronary Vessels; Disease Models, Animal; Dogs; Fatty Acids; Female; Guanethidine; Hypotension; Male; Pentobarbital; Propranolol; Spinal Cord

Topics: Animals; Antihypertensive Agents; Chlorisondamine; Disease Models, Animal; Drug Evaluation, Preclinical; Guanethidine; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Phentolamine; Propranolol; Rats; Sotalol; Stress, Physiological

Topics: Animals; Cardiomyopathies; Chlorisondamine; Disease Models, Animal; Female; Guinea Pigs; Heart Failure; Heart Ventricles; Male; Myocardium; Norepinephrine; Spleen; Stress, Physiological; Tritium

Topics: Animals; Atropine Derivatives; Chlorisondamine; Disease Models, Animal; Female; Motor Activity; Parasympathetic Nervous System; Parasympatholytics; Rats; Stomach Ulcer; Vagotomy, Truncal

Topics: Animals; Blood Pressure; Chlorisondamine; Disease Models, Animal; Ganglia, Sympathetic; Heart Rate; Hypertension, Portal; Hypotension; Male; Nitroprusside; Portal Vein; Rats; Rats, Inbred Strains; Reference Values; Rheology; Vascular Resistance

Topics: Animals; Blood Pressure; Blood-Brain Barrier; Brain; Brain Stem; Central Nervous System; Chlorisondamine; Desoxycorticosterone; Disease Models, Animal